Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to specifically target and eliminate cancer cells in difficult to treat tumors. By integrating cutting-edge research, we aim to enhance the body’s immune response to effectively combat cancer cells. Our mission is to revolutionize cancer care and provide patients with new, life-changing therapeutic options.
Ventuno Biotech announces today the receipt of the BPI French Tech Emergence Grant (Bourse French Tech Emergence – BFTE). This ...
Ventuno Biotech announces today the receipt of the Deeptech label from BPI France
...Ventuno Biotech is featured in the February 14th issue of 15h Biotech Express by BIOTECH FINANCE. Read online in BIOTECH ...
Follow us on